LDC (Managers) Limited has divested Synexus Clinical Research to Jaguar Holdings Company, a holdings company of Pharmaceutical product Development (PPD).

The $258.33m transaction generates 2.3x money multiple for LDC and enables Synexus to achieve a substantial growth in the market.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

JSS Medical Research plans to establish its presence and provide its services to clients in Europe and surrounding regions by acquiring Bonne Sante, a marketing company specialised in promotion of gastroenterology products.

The acquisition enables both companies to improve their operational efficiencies and international business development and expand their client services.

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact